Five things for pharma marketers to know: Monday, April 10, 2017
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
SXSW’s health track finally got a seat at the big-kids table.
Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema
The internet strongly agrees there’s an artificial intelligence revolution going on, and it’s come to pharma marketing.
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.